A Case Report of Primary Biliary Cholangitis Combined with Ankylosing Spondylitis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Oct 13

PMID 37832080

Authors

Chunfeng Hou

Chunfeng Ren

Luan Luan

Shujie Li

Affiliations

Soon will be listed here.

Abstract

Rationale: A chronic autoimmune liver disease known as primary biliary cholangitis (PBC) that selectively destructs small intrahepatic biliary epithelial cells and may result in biliary cirrhosis and eventually liver transplantation or death. PBC is associated with various other extrahepatic autoimmune diseases; however, the combination of PBC with ankylosing spondylitis has been rarely reported in the literature. Here, we reported a case of PBC with ankylosing spondylitis to improve our understanding of such coexistence and provide new ideas for the treatment of such patients.

Patient Concerns: A 54-year-old man was presented to the Department of Rheumatology because of an abnormal liver function test for 7 years, chest and back pain for 1 year, and low back pain for 2 months.

Diagnoses: Primary biliary cholangitis, ankylosing spondylitis, and old pulmonary tuberculosis.

Interventions: The patient refused to use nonsteroidal anti-inflammatory drugs, conventional synthetic disease-modifying antirheumatic drugs, and biologic disease-modifying antirheumatic drugs; thus, he was treated with methylenediphosphonate (99Tc-MDP) and ursodeoxycholic acid (UDCA).

Outcomes: The patient achieved remission with UDCA and 99Tc-MDP therapy.

Lessons: In the treatment of PBC combined with other disorders, the characteristics of different diseases should be considered. The patient reported herein was treated with 99Tc-MDP and UDCA, and his condition improved; thus, we consider 99Tc-MDP to be an effective treatment. Furthermore, in line with the current understanding of the pathogenesis of PBC and ankylosing spondylitis, we hypothesize that interleukin-17 inhibitor is an effective treatment for such patients.

Citing Articles

Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor.

Qi Y, Ma Y, Duan G Int J Mol Sci. 2025; 25(24.

PMID: 39769418 PMC: 11727972. DOI: 10.3390/ijms252413656.

References

Cheng-Chung Wei J, Chen H, Hsieh T, Lan H, Tseng J, Liu C . Clinical practice recommendations for the use of imaging in the diagnosis and management of axial spondyloarthritis in Taiwan. Int J Rheum Dis. 2019; 23(1):24-36. DOI: 10.1111/1756-185X.13679. View

Resorlu H, Kilic S, Isik S, Gokmen F . Successful infliximab therapy in a patient with comorbid spondyloarthritis, primary biliary cirrhosis and generalized morphea. Acta Clin Belg. 2017; 72(5):365-368. DOI: 10.1080/17843286.2017.1290567. View

Niveloni S, Dezi R, Pedreira S, Podesta A, Cabanne A, Vazquez H . Gluten sensitivity in patients with primary biliary cirrhosis. Am J Gastroenterol. 1998; 93(3):404-8. DOI: 10.1111/j.1572-0241.1998.00404.x. View

Hong Y, Yoon K, Cho M . Primary Biliary Cholangitis with Ankylosing Spondylitis. Korean J Gastroenterol. 2022; 79(6):270-273. DOI: 10.4166/kjg.2022.048. View

Lleo A, Leung P, Hirschfield G, Gershwin E . The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Semin Liver Dis. 2019; 40(1):34-48. DOI: 10.1055/s-0039-1697617. View

Yeremenko N, Paramarta J, Baeten D . The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis. Curr Opin Rheumatol. 2014; 26(4):361-70. DOI: 10.1097/BOR.0000000000000069. View

Carey E, Ali A, Lindor K . Primary biliary cirrhosis. Lancet. 2015; 386(10003):1565-75. DOI: 10.1016/S0140-6736(15)00154-3. View

Kingham J, Parker D . The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut. 1998; 42(1):120-2. PMC: 1726939. DOI: 10.1136/gut.42.1.120. View

Tsianos E, Hoofnagle J, Fox P, Alspaugh M, Jones E, Schafer D . Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 1990; 11(5):730-4. DOI: 10.1002/hep.1840110504. View

10.

Mackay I . Clustering and commonalities among autoimmune diseases. J Autoimmun. 2009; 33(3-4):170-7. DOI: 10.1016/j.jaut.2009.09.006. View

11.

Li H, Guan Y, Han C, Zhang Y, Liu Q, Wei W . The pathogenesis, models and therapeutic advances of primary biliary cholangitis. Biomed Pharmacother. 2021; 140:111754. DOI: 10.1016/j.biopha.2021.111754. View

12.

Ma W, Chen D . Immunological abnormalities in patients with primary biliary cholangitis. Clin Sci (Lond). 2019; 133(6):741-760. DOI: 10.1042/CS20181123. View

13.

Huang C, Cheng-Chung Wei J, Chang W, Chiou S, Chou C, Lin Y . Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. J Rheumatol. 2014; 41(6):1104-11. DOI: 10.3899/jrheum.130515. View

14.

Shi T, Zhang T, Zhang L, Yang Y, Zhang H, Zhang F . The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis. Medicine (Baltimore). 2015; 94(44):e1888. PMC: 4915885. DOI: 10.1097/MD.0000000000001888. View

15.

Beuers U, Gershwin M, Gish R, Invernizzi P, Jones D, Lindor K . Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Clin Res Hepatol Gastroenterol. 2015; 39(5):e57-9. DOI: 10.1016/j.clinre.2015.08.001. View

16.

Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin M . The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol. 2015; 48(2-3):301-15. DOI: 10.1007/s12016-015-8471-1. View

17.

Tan Y, Wang Y, Zhang M, Han Y, Huang C, Zhang H . Clonal Characteristics of Circulating B Lymphocyte Repertoire in Primary Biliary Cholangitis. J Immunol. 2016; 197(5):1609-20. DOI: 10.4049/jimmunol.1600096. View

18.

Abdulkarim A, Petrovic L, Kim W, Angulo P, Lloyd R, Lindor K . Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?. J Hepatol. 2004; 40(3):380-4. DOI: 10.1016/j.jhep.2003.11.033. View

19.

. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017; 67(1):145-172. DOI: 10.1016/j.jhep.2017.03.022. View

20.

Braun J, Sieper J . Ankylosing spondylitis. Lancet. 2007; 369(9570):1379-1390. DOI: 10.1016/S0140-6736(07)60635-7. View